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Due to its intrinsic properties, there has been growing interest in human amniotic
membrane (hAM) in recent years particularly for the treatment of ocular surface disorders
and for wound healing. Herein, we investigate the potential use of hAM and amnion-
chorion membrane (ACM) in oral surgery. Based on our analysis of the literature,
it appears that their applications are very poorly defined. There are two options:
implantation or use as a cover material graft. The oral cavity is submitted to various
mechanical and biological stimulations that impair membrane stability and maintenance.
Thus, some devices have been combined with the graft to secure its positioning
and protect it in this location. This current opinion paper addresses in detail suitable
procedures for hAM and ACM utilization in soft and hard tissue reconstruction in the
oral cavity. We address their implantation and/or use as a covering, storage format,
application side, size and number, multilayer use or folding, suture or use of additional
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protective covers, re-application and resorption/fate. We gathered evidence on pre-
and post-surgical care and evaluation tools. Finally, we integrated ophthalmological
and wound healing practices into the collected information. This review aims to help
practitioners and researchers better understand the application of hAM and ACM in the
oral cavity, a place less easily accessible than ocular or cutaneous surfaces. Additionally,
it could be a useful reference in the generation of new ideas for the development of
innovative protective covering, suturing or handling devices in this specific indication.
Finally, this overview could be considered as a position paper to guide investigators to
fulfill all the identified criteria in the future.
Keywords: amniotic membrane, oral and maxillo-facial surgery, oral mucosa, ophthalmology, wound healing
INTRODUCTION
The human amniotic membrane (hAM), or amnion, is the
innermost layer of fetal membranes. It is composed of a
single layer of epithelial cells, a basement membrane, and an
avascular stroma, underlayered by the chorion. The thickness
of human term amnion varies among individuals and depends
on the location of the sample (70–180 µm thick) (Chen
et al., 2012; Gremare et al., 2019). Both amnion and chorion
contain mesenchymal stromal cells (MSCs) (Parolini et al.,
2008) and variable quantity of growth factors depending
on the fetal membranes (McQuilling et al., 2017) and/or
the preservation methods (Russo et al., 2011; McQuilling
et al., 2017). Basic preservation methods for hAM are
cryopreservation, lyophilization and storage in a dry form
(Jirsova and Jones, 2017), with questionable cell survival after the
cryopreservation process despite the addition of cryoprotective
agents (Laurent et al., 2014).
The beneficial effects of hAM have been widely described
in the literature. It is immunotolerant, biocompatible and has
suitable mechanical properties (permeability, stability, elasticity,
flexibility, and resorbability) (Chen et al., 2012). Additionally it
possesses anti-fibrotic (Ricci et al., 2013), anti-scaring (Mamede
et al., 2012), anti-microbial (Chen et al., 2019) anti-inflammatory
(Bailo et al., 2004; Wolbank et al., 2007) and analgesic properties
(Rama et al., 2001; Dua et al., 2004; Gajiwala and Gajiwala, 2004).
It modulates angiogenesis, having both pro- and anti-angiogenic
properties (Mamede et al., 2012; Gholipourmalekabadi et al.,
2019) and induces epithelialization and wound healing (Mamede
et al., 2012; Gholipourmalekabadi et al., 2019). Finally, it has a
low immunogenicity (Kubo et al., 2001), which makes it suitable
as an allograft.
To date, ophthalmology is one of the most popular
applications of hAM in routine use. The tissue is used as a
graft, spread onto the ocular surface to treat epithelial defects or
ulcers, or as a bandage to cover the ocular surface to promote
healing (Dua et al., 2004; Gomes et al., 2005; Baradaran-Rafii
et al., 2007). Several reports have described its use as a covering
for the management of wound healing (treatment of chronic
ulcers, full and partial thickness burns, skin graft donor sites, over
grafting and wounds) (Singh et al., 2004; Mermet et al., 2007;
Insausti et al., 2010; Valiente et al., 2018). In both indications,
hAM application was facilitated by the access to the tissues being
treated (eyes and skin) and by an appropriate description of hAM
grafting or covering in the literature.
Since the mid-1990s, there has been a growing interest in using
hAM for oral surgery to accelerate tissue regeneration. Chorion
and amnion-chorion membrane (ACM) products are also very
popular in this indication because they provide not only better
handling and thickness, but also provide intrinsic growth factors
(Koob et al., 2015; McQuilling et al., 2017). Two recent systematic
reviews examined hAM, chorion and ACM benefits for wound
healing in various areas of oral reconstruction (Fenelon et al.,
2018a; Gulameabasse et al., 2020).
The antimicrobial characteristics of hAM - its ability to
manage bacterial infection and biofilm growth and its ability
to promote epithelialization - are fundamental properties that
benefit to these three tissue sites. The oral cavity and eye
share the common property of being in a moist environment
with constant movements; severe aqueous tear deficiency, or
dry eye, is one major limiting factor for successful hAM
transplantation (Shimazaki et al., 2000; Santos et al., 2005).
On the other hand, both oral and dermal mucosa exhibit
similar macroscopic epithelialization during the wound healing
process, which proceeds much faster with a lower inflammatory
response and relatively little to no scar formation for oral wounds
(Turabelidze et al., 2014).
We have accumulated considerable evidences on hAM use
for bone regeneration from experimental studies (Gindraux and
Obert, 2010; Obert et al., 2012; Gindraux et al., 2013; Laurent
et al., 2014; Gindraux et al., 2017; Laurent R. et al., 2017;
Fenelon et al., 2018b; Gindraux et al., 2018; Fenelon et al.,
2019; Gualdi et al., 2019; Fenelon et al., 2020; Etchebarne et al.,
2021; Fénelon et al., 2021). The diversity of the conditions
and methods of membrane application make it difficult to find
relevant information in the literature on surgery and tools to
judge its efficacy.
The aim of this review is to help practitioners better
understand hAM and ACM applications in the oral cavity.
The healing effectiveness of fetal membranes has been widely
addressed (Fenelon et al., 2018a; Gulameabasse et al., 2020).
We focused on clinical hAM/ACM implantation or use as a
covering, storage format, application side, size and number,
multilayered use or folding, suturing or use of additional
protective covers, re-application and resorption/rate. At the same
time, we gathered evidence on pre- and post-surgical care and
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evaluation tools. Finally, we compared our collected information
to ophthalmological and wound healing practices.
In an original way, this overview could generate new
ideas for the development of innovative hAM/ACM protective
covering, suturing or handling devices in the chosen indication.
Most important, it could be used as position paper to guide
investigators to fulfill all the identified criteria in the future.
hAM AND ACM APPLICATION IN ORAL
SURGERY
Application Method: Implantation or
Covering Options
In the oral cavity, there are no homogeneous naming practices
or consensus about hAM/ACM application. Two procedures
have been described: we termed the first “implanted membrane”
when the graft was buried beneath the gingiva and the second,
“covering graft material” when it was used to cover a mucosal
defect and left exposed in the mouth. In the first case, hAM/ACM
have guided tissue or bone regeneration (GTR/GBR) membrane
functions for periodontal surgery, wound management after
implant surgery, bisphosphonate-related osteonecrosis of the jaw
(BRONJ) and Schneider membrane perforations repair (Table 1).
In the second, hAM/ACM has been incorporated in mandibular
vestibuloplasty or oronasal fistulae management (Table 2).
When used as an implanted membrane, the main application
remains periodontal surgery. Four studies looked at its use as
root coverage for gingival recessions, among which three had
a coronally advanced flap (Shetty et al., 2014; Jain et al., 2017;
Rehan et al., 2018). In these cases, the hAM was applied on the
root surface and the flap was sutured over it, taking care not
to move or fold it. Sharma and Yadav (2015) raised a partial
thickness flap with a double papilla flap technique, with the hAM
being applied against the root surface underneath the flap and
the suturing performed above it. Furthermore, hAM was used in
bone furcation defects in three studies. Some authors first raised a
full thickness flap to make a bone graft in the furcation defect and
then covered the bone graft using hAM (Kothiwale et al., 2009;
Kumar et al., 2017). In these studies, hAM was adapted to the
size of the defect at the surgical site; stability was obtained with a
drop of saline solution to prevent the hAM from shriveling. Kaur
and Bathla (2018) did the same procedure, but with a plasma-
rich in fibrin (PRF) membrane instead of a bone graft in the
furcation and covered it with hAM. In three studies, hAM was
used in vertical interproximal bone loss. In one study, a full-
thickness flap was raised and the hydroxyapatite filled defect
was covered with hAM; the flap was sutured above the amnion
(Kumar et al., 2015). Similarly, in another study, Bio-Oss bone
xenograft was covered with a double layer of hAM and the
excess folded; the suture was placed above the grafted area (Kiany
and Moloudi, 2015). In a different approach, a full-thickness
flap was raised and ACM potentialized with a drop of saline
combined with freeze-dried bone allograft (FDBA) were applied
on the root surface (Hamada et al., 2020). The most coronal
part of the ACM, extending from approximately 3 mm over
the cement-enamel junction, was then folded over the FDBA.
Another layer of ACM was then applied over the ACM/FDBA
pair before flap suturing. Finally, three studies tested ACM in
alveolar ridge preservation. After extracting the teeth and raising
full-thickness flaps, the sockets were filled with demineralized
FDBA (DFDBA) covered with ACM, which was tucked in the
vestibular and lingual parts of the flap; the gingiva was sutured
above it (Faraj et al., 2020). In one study, ACM was secured
by sutures; primary closure was not expected, leaving the ACM
deliberately exposed (Hassan et al., 2017). In another one, a mix
of hydroxyapatite and particulate mineralized bone xenograft
covered with ACM was grafted and the gingiva was sutured
over it in an inverse “Figure of 8”, providing excellent stability
(Cullum and Lucas, 2019).
Two studies investigated hAM or ACM use in wound
management after implant surgery. hAM was applied after dental
implant placement and the gingiva was sutured above it (Velez
et al., 2010) or a full-thickness flap around the implants was raised
and ACM was applied around the implant under the periosteum
(De Angelis et al., 2019). The membrane was secured using
polytetrafluoroethylene (PTFE) sutures and left exposed during
the healing phase.
In an original way, hAM was investigated for the management
of BRONJ (Ragazzo et al., 2018). After a mucoperiosteal incision
with mesial and distal drainage, as well as excision of the necrotic
and infected tissues, hAM was positioned on the bone, with the
gingiva sutured tightly above it.
Finally, ACM was tested to repair Schneider membrane
defects after perforations due to manual hand instrumentation in
maxillary sinus augmentation procedures with a lateral approach
window (Holtzclaw, 2015). Using the same approach as the
surgery that created the perforation, a first layer of dried ACM
was applied in the sinus against the perforation and extended by
3 mm from the defect. Once hydrated with blood, the ACM self-
adhered well, allowing the investigators to leave it un-sutured.
Particulate bone allograft was combined with bone xenograft and
covered with another layer of ACM before closing by flap suture.
When used as covering graft material, five studies have
investigated hAM grafts for mucosal defects. In three of these,
hAM was directly sutured to the adjacent mucosa around
the defect after excision of the lesion (Lai et al., 1995; Kar
et al., 2014; Amemiya et al., 2015). Differently, Khademi et al.
(2013) fixed the hAM with sutures to the underlying mucosal
membrane. Arai et al. (2012) stabilized the hAM by applying
pressure with a dressing of antibiotic ointment gauze, which was
removed after 1 week.
Five studies investigated hAM in mandibular vestibuloplasty.
After having done Clark’s or Kazandjian’s technique and sutured
the mucosal flap to the periosteum, Guler et al. (1997) closed
the wound by suturing the hAM graft directly to the adjacent
oral mucosa, without further protection in the oral cavity, but
with a tight compression dressing over the lower lip. Samandari
et al. (2004) performed Clark’s technique and the remaining
wound was closed with an hAM graft, sutured to the adjacent
oral mucosa. The graft was protected by a splint covered with
3% tetracycline topical gel and stabilized with two pieces of
wire, removed after 1 week. Using the same technique, hAM was
































Pre- and post-surgical care Fate/Resorption References and
year




No Mouth rinses with Chlorhexidine ND Shetty et al., 2014





No tooth brushing for 3 weeks Mouth rinses
with Chlorhexidine for 3 weeks
ND Sharma and Yadav,
2015




10 × 10 mm (?)
(rq: written
1 × 1 mm in
the article)
No Mouth rinses with Chlorhexidine just before
surgery and continued after surgery
Improvement in
width of keratinized
gingiva at 3 months
and 6 months
Jain et al., 2017





No Pre-surgical mouth rinses with Chlorhexidine
Mouth rinses for 4 weeks
No tooth brushing for 4 weeks
Suture removal at day 10
ND Rehan et al., 2018






No Antibiotics for 1 week
Mouth rinses with Chlorhexidine twice a day for
4 weeks Suture removal at day 7
ND Kothiwale et al., 2009






No Antibiotics Mouth rinses with Chlorhexidine for
1 week
ND Kumar et al., 2017




to figure 4 in the article
Adapted to size
of bone defect
No Antibiotics for 5 days
Mouth rinses with Chlorhexidine 2 times a day
for 2 weeks
Tooth brushing with a soft toothbrush
Suture removal at day 7














with a double layer
of hAM, with
excess folded
Antibiotics for 1 week
Mouth rinses with Chlorhexidine for 4 weeks No
tooth brushing for 2 weeks, then only using an
extra-soft toothbrush Suture removal at
2 weeks










No Antibiotics for 1 week
Mouth rinses with Chlorhexidine for 2 weeks
At 3 and 6 days:
Epithelialization
obtained faster on
the hAM side than
on the standard
procedure side
Velez et al., 2010































































No No antibiotics Epithelialization in
2 weeks
approximately






8 × 8 mm No Pre-operative care: mouth rinses
with Chlorhexidine for 3 days
Antibiotics for 5 days Tooth







21 Dehydrated Adapted to size
of defect
No Prophylactic antibiotics and mouth
rinses with Chlorhexidine before
surgery
Antibiotics for 10 days Mouth rinses
with hydrogen peroxide for 2 weeks
Epithelialization in
2 weeks











Mouth rinses (not with
Chlorhexidine)










25 × 15 mm














Antibiotics for 1 week
Mouth rinses with Chlorhexidine for
2 weeks
No tooth brushing for 2 weeks at
the site
















Antibiotics for 10 days
Nasal decongestants:
Oxymetazoline nasal spray for
3 days, Pseudoephedrine for
1 week
ND Holtzclaw, 2015










































TABLE 2 | hAM used as a covering graft material.
Indication No. of
patients
Graft storage format Graft size (mm)/Side Multilayered
use/Folding
Post-surgical care/Additional






25 Fresh Adapted to the size of the
defect
No Nasogastric feeding for 1 week Epithelialization (with no indication
about the time)





10 Dried and irradiated Various sizes: from
21 × 18 mm to 60 × 35 mm
mesenchymal side facing the
wound
No hAM placed directly on the wound,
stabilized using a pressure dressing of
antibiotic ointment gauze removed at
day 6
Oral feeding
At day 6: hAM nearly invisible
Full epithelialization obtained in a
maximum of 6 weeks




50 Cryopreserved 100 × 100 mm, then adapted
to size of defect
No ND At 3 weeks: good granulation tissue








34 Cryopreserved 40 × 40 mm No Nasogastric feeding for 1 week At 3 months: good epithelialization in
100% of patients
Kar et al., 2014
Mucosal defect after
excision of benign or
precancerous
lesions
5 Autologous oral mucosal
epithelial cell cultured on
de-epithelialized
cryopreserved hAM








Tight compression dressing over the
lower lip
Day 10: hAM is not differentiated from
the surrounding tissues; epithelialization
continuation in the graft
After 2 weeks: complete resorption of
hAM
After 3 weeks: graft zone covered by
oral mucosa






7 Fresh 60 × 100 mm2, then adapted
to size of defect mesenchymal
side facing the periosteum
No Protection with a splint covered with a
tetracycline topical gel and fixed with
sutures, removed after 1 week
After 2 weeks: persistence of small
segments of hAM
After 3 weeks: complete resorption of
the hAM, grafted zone still identifiable
After 3 months: no difference between






10 Preserved in glycerol 60 × 100 mm3, then adapted
to size of defect mesenchymal
side facing the periosteum
No Use of a suction catheter stent fixed to
surrounding mucosa, removed after
week 1
After 3 weeks: complete resorption of
the hAM, grafted zone still identifiable
After 3 months: no difference between





10 Preserved in glycerol 60 × 100 mm, then adapted to
size of defect
No Protection with a splint secured with
bone screws, removed at day 7, with
cleaning of the surgical site




2 Dried and irradiated 40 × 20 mm, then adapted to
size of defect
No Surgical splint fixed over the hAM (with
mini-screws) and removed at 1 week
Oral feeding started the day after
surgery
At 1 week: hAM nearly invisible
Full epithelialization obtained in a




Oronasal fistulae 4 Cryopreserved 50 × 50 mm, then adapted to
size of defect
5 layers Protection with a palatal plate ND Rohleder et al.,
2013
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sutured to the underlying periosteum and stabilized for 1 week
with a suction catheter stent (Sharma et al., 2011) or a surgical
splint secured with miniature screws (Kothari et al., 2011; Tsuno
et al., 2014).
Finally, Rohleder et al. (2013) explored the possibility of
using hAM grafts in oronasal fistulae of the hard palate. After
freshening the layers of the fistulae, multiple layers of hAM were
sutured to the nasal epithelium and subsequently to the oral
mucosa of the palate. The whole grafted site was then protected
with a palatal plate.
Graft Storage Format
In our review, hAM was implanted or used as a covering graft
in six studies in its cryopreserved format (Velez et al., 2010;
Khademi et al., 2013; Rohleder et al., 2013; Kar et al., 2014;
Amemiya et al., 2015; Ragazzo et al., 2018) and in 12 studies in its
lyophilized or dried format with additional gamma-sterilization
in some cases (Guler et al., 1997; Kothiwale et al., 2009; Arai
et al., 2012; Shetty et al., 2014; Tsuno et al., 2014; Kiany and
Moloudi, 2015; Kumar et al., 2015; Sharma and Yadav, 2015;
Jain et al., 2017; Kumar et al., 2017; Kaur and Bathla, 2018;
Rehan et al., 2018). A non-usual format of fresh or glycerol-
preserved hAM was investigated in four studies (Lai et al., 1995;
Samandari et al., 2004; Kothari et al., 2011; Sharma et al., 2011).
Non-additional processes (de-epithelization, decellularization,
. . .) were applied to the hAM.
ACM was used only in its dehydrated format in six
studies, sometimes de-epithelized and irradiated (Holtzclaw,
2015; Hassan et al., 2017; Cullum and Lucas, 2019; De Angelis
et al., 2019; Faraj et al., 2020; Hamada et al., 2020).
Graft Size and Side
Our analysis of graft sizes found huge variability between the
studies. The sizes were different between the tissue banks who
commercialized or delivered the membranes. Another factor in
this variability was the size of the defects in the oral cavity. The
smallest size was 8 by 8 mm to manage alveolar ridge preservation
(Cullum and Lucas, 2019); the biggest one was 60 by 35 mm to
cover the whole buccal mucosa defect after excision of a lesion
(Arai et al., 2012).
Five studies applied the amnion with its mesenchymal side
facing the underlying surface (periosteum, mucosa). In surgical
wounds after implant surgery, hAM was implanted with its
stromal layer in contact with the wound, facilitating its adhesion
(Velez et al., 2010). In the management of surgical defects of
the oral mucosa, and mainly in mandibular vestibuloplasty,
the hAM’s mesenchymal side was placed on the wound or the
periosteum (Guler et al., 1997; Samandari et al., 2004; Sharma
et al., 2011; Arai et al., 2012).
Graft Number, Multilayered Use and
Folding
When patients have defects in multiple sites, it seems that all
the sites were treated at the same time (Cullum and Lucas,
2019) but, mostly, only one site was cured. Four studies reported
multilayered hAM or ACM use (Rohleder et al., 2013; Kiany and
Moloudi, 2015; Hamada et al., 2020). As previously described, five
layers of cryopreserved hAM were used to close oronasal fistulae
of the hard palate (Rohleder et al., 2013). In the remainder of
the studies, a double layer of membrane was folded around bone
substitutes (Holtzclaw, 2015; Kiany and Moloudi, 2015; Hamada
et al., 2020).
Surgical Care and Additional Protective
Coverage
Pre- or post-surgical care was somewhat dissimilar between the
studies, mainly because of inherent differences in the surgery
itself, rather than the hAM application.
Antibiotics (2 g of Amoxicillin, 600 mg of Clindamycin
in case of allergy) for 5–10 days and/or 0.12% Chlorhexidine
mouth rinses were prescribed before and after hAM/ACM
implantation. Sometimes, hydrogen peroxide was recommended
because ACM contains bioactive charged proteins that can bind
to the chlorhexidine cation and reduce the rate of cellular
migration across the membrane (De Angelis et al., 2019; Faraj
et al., 2020). Suspension of tooth-brushing was suggested for
either 2 weeks (Kiany and Moloudi, 2015; Hamada et al., 2020),
3 weeks (Sharma and Yadav, 2015), or 4 weeks (Rehan et al.,
2018) after hAM/ACM implantation. Tap water rinsing or soft
toothbrush were recommended in some cases to complete the
local hygiene directly after surgery (Kaur and Bathla, 2018;
Cullum and Lucas, 2019). Sutures were removed after 1 week in
most studies (Kothiwale et al., 2009; Kumar et al., 2015; Kaur and
Bathla, 2018); with other studies waiting 10 days (Rehan et al.,
2018) or 2 weeks (Kiany and Moloudi, 2015).
When used as covering, pressure was applied to the hAM
with a dressing of antibiotic ointment gauze for 1 week (Arai
et al., 2012) or a splint covered with 3% tetracycline topical
gel protecting the graft for 1 week (Samandari et al., 2004).
Nasogastric feeding was initiated for 1 week in two studies (Lai
et al., 1995; Kar et al., 2014). Oral feeding was started the day after
surgery in two other studies (Arai et al., 2012; Tsuno et al., 2014).
When specified, sutures were removed after 1 week (Samandari
et al., 2004; Amemiya et al., 2015).
Graft Re-application and Resorption
Only one application was reported in all these studies, meaning
that no re-interventions were needed to apply additional hAM.
No information was found about the membrane’s resorption
following its implantation. Velez et al. (2010) noticed that
cryopreserved hAM induced earlier epithelialization than a
standard procedure in wound management around implants,
in which patients were their own controls. This speedy healing
was shown after 3 days and was significant after 6 days. After
2 weeks, both sides were equivalent in terms of epithelialization.
With a de-epithelialized and/or dehydrated ACM, some authors
reported epithelialization after approximately 2 weeks (Hassan
et al., 2017; Faraj et al., 2020), with mature epithelium visible
after 4 weeks (Cullum and Lucas, 2019) and an increase in
keratinized tissue width observed at each follow-up visit (7, 15,
and 60 days, with the last date being the prosthetic delivery) (De
Angelis et al., 2019). With lyophilized hAM, keratinized gingiva
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was significantly improved between baseline and the 3-month
and 6-month post-surgery follow-up visits (Jain et al., 2017).
More information about membrane resorption was found
when hAM was used as a covering graft material. When fresh
or glycerol-preserved hAM was used, some authors reported
persistence of small sections of the membrane after 2 weeks;
full resorption after 3 weeks, with the grafted zone being still
identifiable at that time (Samandari et al., 2004; Sharma et al.,
2011). After 3 months, there were no differences between the
grafted sites and the surrounding oral mucosa. Similarly, dried
amnion was nearly invisible after 1 week (Arai et al., 2012;
Tsuno et al., 2014). Guler et al. (1997) could not distinguish
lyophilized hAM from the surrounding tissues at 10 days post-
grafting, with complete resorption being obtained after 2 weeks.
After 3 weeks, the grafted zone was covered with oral mucosa.
Complete epithelialization was observed in 1 month (Khademi
et al., 2013; Amemiya et al., 2015) to 3 months (Kar et al.,
2014) after cryopreserved hAM grafting; after 3 weeks (with
epithelialization continuing at day 10) with the lyophilized one
(Guler et al., 1997) and after a maximum of 6 weeks associated
with a sufficient keratinized gingiva level with the dried one (Arai
et al., 2012; Tsuno et al., 2014).
Photography was the main evaluation tool used to follow
the epithelialization and/or keratinization of the grafted area.
Scar contracture information was poorly reported. Some authors
evaluated scarring and divided it on a clinical basis (Velez et al.,
2010; Arai et al., 2012); others assessed mucosal suppleness
(Kar et al., 2014).
X-rays were used to evaluate hAM/ACM GTR/GBR function
in the protection of underlying bone substitute (Kiany and
Moloudi, 2015; Kumar et al., 2015; Cullum and Lucas, 2019).
One study used CT scan to follow bone healing (Ragazzo et al.,
2018), another one used histology to assess hAM resorption and
epithelialization (Samandari et al., 2004).
Since hAM is widely recognized as relieving pain, some
authors evaluated it using a pain scale. Velez et al. (2010) used
an analog Likert scale, going from 0 (no pain) to 10 (worst pain
imaginable). Other studies used a visual analog scale (VAS) (Kar
et al., 2014; Tsuno et al., 2014; Hassan et al., 2017; De Angelis
et al., 2019). Some authors rated it in three grades (none/mild,
moderate and severe) (Khademi et al., 2013), sometimes also




Application Method: Implantation or
Covering Options
In the oral surgery field, hAM is more frequently implanted and
then covered by the gingiva, instead of being used as covering
material left exposed in the buccal cavity. Interestingly, ACM has
only been used as an implant. The role of the membrane as a
dressing in oral surgery is superimposable to what is reported for
ophthalmology and wound healing.
This double-option application is a common point within
the ophthalmological field. When used as a “graft” or “inlay
technique”, hAM is intended to act as a basement membrane for
epithelial regeneration and is placed within the boundaries of the
diseased area. When it is used to cover the ocular surface and
protect the underlying healing epithelium, it is referred to as a
“patch” or “onlay or overlay technique” (Letko et al., 2001; Dua
et al., 2004). Erosion or shallow stromal defects in the center of
the cornea might be an indication for hAM patch due to optical
reasons; for peripheral lesions, an hAM graft might be preferred
(Resch et al., 2006).
In our literature review, we noticed that none of implanted
hAM/ACM were directly sutured; in two cases the graft’s stability
was ensured by sutures (Hassan et al., 2017; De Angelis et al.,
2019). From Gulameabasse’s review, implanted ACM was sutured
in four studies for stabilization, otherwise it was only applied to
the surgical site (Gulameabasse et al., 2020). When hAM was used
as a cover, it was sutured in place in 9 of the 11 studies; two studies
did not provide enough detail (Guler et al., 1997; Samandari et al.,
2004). Suture materials ranged from 4/0 VICRYL R© (Sharma et al.,
2011; Khademi et al., 2013) to 5/0 polyglactin 910 sutures (Guler
et al., 1997) or much thinner sutures such as 7/0 PROLENE R©,
removed 1 week later (Amemiya et al., 2015).
In contrast to hAM application in oral surgery, sutures are
always necessary in ophthalmology. The suture material used
in conjunction with the hAM is usually 10-0 nylon, 8- to 10-0
VICRYL R© or PROLENE R©. Sutures may be interrupted, running,
or mattress type. Mattress sutures are generally placed tangential
to the limbus, tacking the membrane to the episclera or superficial
sclera. Sutures can be removed at 3 weeks (Dua et al., 2004). In
the overlay technique, the patch is secured to the surrounding
conjunctiva–episclera with interrupted 8-0 or 9-0 VICRYL R©
sutures. An additional 10-0 VICRYL R© purse-string suture may be
placed in the midperipheral cornea (Sippel et al., 2001).
In the ophthalmological field, some improvements had been
implemented to avoid hAM suturing and suture removal. The
amnion can be kept in place with a tissue adhesive (fibrin glue,
gelCORE) or mounted on a plastic structure (Kheirkhah et al.,
2008; Kotomin et al., 2015; Shirzaei Sani et al., 2019). Prokera R©
(Bio-tissue Inc., Miami, FL, United States) is a commercially
available medical device that acts as a sutureless biological
bandage; it is made of cryopreserved amniotic membrane clipped
to a thermoplastic ring set (Kheirkhah et al., 2008). Similarly,
in the AmnioClip-plus device, the hAM is clamped in a
ring system (Kotomin et al., 2015). All these techniques have
several advantages inasmuch as they can be performed under
topical anesthesia, the surgery time is shorter and there are
no suture-related complications (Kheirkhah et al., 2008). These
fixation devices have applications in oral surgery and deserve
to be developed, especially when the membrane is used as a
coverage material.
On the contrary, no suturing is required for wound healing
since the wound allows it to self-adhere. Sometimes, sterile
tweezers are used to remove any air bubbles under the
hAM to ensure it is in close contact with the wound bed
(Valiente et al., 2018). Some authors also blow sterile 42◦C
air for 5 min to improve adhesiveness (Lo et al., 2010).
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The amnion is left uncovered and undisturbed (Gajiwala and
Gajiwala, 2004) or protected by an additional covering material
(see below). Interestingly, fibrin glue (Tissucol Baxter, Vienna,
Austria) is used on wounds with a spraying technique to avoid
shearing off through manipulations before the hAM is applied
(Loeffelbein et al., 2014).
Graft Size and Side
In oral surgery, graft sizes vary between the studies, depending on
the defect size and shape. Small sizes corresponded to lyophilized
or dehydrated hAM/ACM; these formats allow for easy cutting.
The membranes are often trimmed to match the defect’s shape.
Only hAM is applied regardless of the application side when it
is implanted (one study) or used as a covering graft material
(four studies). We previously reported in an animal model that
cryopreserved hAM seemed to induce greater bone formation
when the mesenchymal side covered the defect (Fenelon et al.,
2020). Although composed of two fetal membranes (amnion
and chorion), the side of ACM application is not important
(Gulameabasse et al., 2020).
The membrane size used in ophthalmology is obviously much
smaller than the one used in oral surgery; however, applying the
mesenchymal or epithelial side has some similarities because AM
orientation, in these indications, seems to be critical for healing.
In the inlay method, hAM covers the defect after trimming
away the excess edges with the epithelial–basement side facing up
(Lee and Tseng, 1997). The hAM thereby functions as a basement
membrane over which new corneal epithelium can grow (Lee
and Tseng, 1997; Sippel et al., 2001). In the overlay technique,
depending on the disease severity, it can cover the entire ocular
surface (cornea, bulbar, forniceal and palpebral conjunctiva) or
just part of it (Dua et al., 2004). In this case, hAM is used primarily
to contain the inflammatory reaction while epithelialization is
occurring beneath the membrane, which is sutured with its
epithelial side against the ocular surface. The mesenchymal side
of the hAM traps inflammatory cells and induces apoptosis,
thereby reducing inflammation.
The size of the membranes used in wound healing is logically
larger since the skin defects are larger, from 2 × 2 cm to
10 × 10 cm (Insausti et al., 2010; Lo et al., 2010; Castellanos
et al., 2016; Valiente et al., 2018; Xue et al., 2018). Very few
publications reported the membrane’s orientation; when it was
specified, it was similar to oral surgery and ophthalmology with
the mesenchymal side facing the wound’s surface (Mermet et al.,
2007; Insausti et al., 2010). In the study by Valiente et al. (2018),
no consideration was given to which side of the hAM was applied
when treating diabetic foot ulcer, with positive effects observed
when using either side.
Graft Number, Multilayered Use and
Folding
Most of the analyzed studies in the oral surgery field feature
single layer hAM application. Because hAM does not have any
space maintenance capabilities, some authors suggested using
multiple hAM layers and reported its usefulness as a barrier
(Rohleder et al., 2013). Two layers of hAM can be folded over
bone allograft, delaying its degradation or enhancing its barrier
function without any consequences (Holtzclaw, 2015; Kiany and
Moloudi, 2015; Hamada et al., 2020). In general, some authors
specify that if the membrane folds over itself, it should not
be unfolded (Gulameabasse et al., 2020). We recognize that
membrane multilayers or folding possibilities are an advantage
to consider in oral surgery.
In ophthalmology, except for deep ulcers, one layer of hAM
is generally sufficient (Lee and Tseng, 1997). If necessary, two
membranes can be used in the same eye: one epithelial side
up and the other, epithelial side down. This combines both
techniques: inlay graft followed by an overlay patch. In this case,
the inner membrane applied to the ocular surface is sutured with
the epithelial side up, acting as a graft. The other, usually larger
membrane is sutured on top of the first, with the mesenchymal
side up. The second membrane acts as a protective bandage for
the first membrane and the cells growing on it. The arrangement
of layer surfaces is not important except for the uppermost layer
which should be placed with the epithelial side up to allow
coverage by corneal epithelial cells (Kruse et al., 1999).
Up to 6 layers of hAM can be used to fill a deep defect (Chen
et al., 2000; Prabhasawat et al., 2001; Nubile et al., 2011). The
hAM is cut into small pieces and placed mesenchymal side down,
layer by layer, to fill the ulcer and cover the defect. Usually,
the top layer is applied with epithelial side up and secured with
10–0 nylon sutures (Kruse et al., 1999; Hanada et al., 2001).
A final hAM is used as a cover with its epithelial side up. The
number of applied layers is also very important, because corneal
epithelium can grow between the hAM layers (Resch et al., 2006).
Along with this multiple individual layer application, hAM may
be used as a “fluffed-up” sheet of membrane or as a multilayer
sheet (John, 2003). In the latter, the membrane is folded on itself
twice which makes it four-layered, or more if needed, much like
folding a blanket (“blanket-fold”) and then anchoring it to the
cornea. In either case, a second single sheet of hAM is placed over
the entire cornea.
As far as we know, multiple layers of hAM are not used for skin
defects. In contrast, there are multiple single-layer application
times (detailed below).
Surgical Care and Use of Additional
Protective Cover
More than ever, the stability of the hAM/ACM in the oral
environment remains to be elucidated. Further investigation is
needed to evaluate whether the membrane is robust enough to
resist the masticatory and salivary effects for a sufficient time
and biodegradable for subsequent repair and maturation of the
mucosal tissues. The use of an additional protective cover would
be highly recommended, no matter the tissue being healed. It
probably also acts on wet environment preservation; humidity
being a factor for the success of hAM transplantation (Shimazaki
et al., 2000; Santos et al., 2005; Fetterolf and Snyder, 2012).
Kiany and Moloudi (2015) attributed the good stability of
hAM, once applied in the oral cavity on the root surface, with
a moist environment, with no need for suturing or fixation.
Nevertheless, when used as a covering material, hAM may need
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further protection to delay its degradation or stop it from shifting.
Different devices have been evaluated: splints either fixed with
bone screws or with sutures, removed after 1 week; palatal plate
or pressure dressings, either directly against the hAM or with an
extra-oral application; suction catheter stents.
Though all these devices are adequate solutions, splints may
prove to be the most useful: they are much more comfortable
thus allow the patient to continue oral feeding (instead of a
nasogastric tube) and they prevent direct contact between the
hAM and the oral environment, thus ensuring good protection.
They also offer the possibility of applying a layer of topical gel,
which can be an antibiotic or an antiseptic. The same advantages
can also be found with palatal plates; 3D printing could have great
promise. Additionally, we suggest that, when used as a covering
material, hAM needs to be preserved at minima using horizontal
mattress sutures with non-absorbable suture. Interestingly, this
procedure was applied in one study: after the palatal epithelial-
connective graft was configured, the wound was covered with
hAM and secured by 3-0 silk non-absorbable mattress sutures
(Martelloni et al., 2019).
Like the oral cavity, the eye has a moist environment subject to
movement, thereby requiring hAM protection. Depending on the
aqueous tear status and the blinking function, a bandage contact
lens, hAM as a temporary patch, or temporary tarsorrhaphy was
added. The contact lens protects the hAM layers from mechanical
and chemical injuries and is removed when the epithelial defect
has healed (Chen et al., 2000; Letko et al., 2001).
In wound healing, a large arsenal of protective additional
coverage options is available, some of which could be used in
the oral surgery field. Some recommendations specify that the
graft should be covered with a non-adherent contact layer [e.g.,
Adaptic (Johnson & Johnson, New Brunswick, NJ, United States)
or Mepitel R© (Mölnlycke Health Care, Gothenburg, Sweden)] and
should not be disturbed, if possible, for at least 1–2 weeks. The
secondary dressing environment should be moist, and a moisture
management dressing suited to the wound type and treatment is
recommended (Fetterolf and Snyder, 2012).
Thus, the following coverings are used: gauge dressing with
appropriate splints as indicated (Gajiwala and Gajiwala, 2004);
lipidocolloid dressing, UrgoTulTM (Laboratoires Urgo, France)
with compression bandages or level II/III compression stockings
(Mermet et al., 2007); silicone dressing (Lo et al., 2010);
petrolatum gauze and a secondary polyurethane (PU) foam
dressing (Alsina-Gibert and Pedregosa-Fauste, 2012); PU foam
(Mepilex, Mölnlycke Health Care, Erkrath, Germany) or PU foil
(3MTM TegadermTM Film, 3M, St. Paul, MN, United States) and
consecutive paraffin gauze (Jelonet, Smith & Nephew GmbH,
Marl, Germany) (Loeffelbein et al., 2014); petrolatum gauze
(Bama-Geve S.L.U, Spain) (Xue et al., 2018); non-adhesive
dressing and a crepe bandage (Valiente et al., 2018).
Graft Re-application and Resorption
Re-application
Graft re-application is a common practice in dermatology with
great benefits; however, it is not very common in ophthalmology
and never done in oral surgery. This wound healing re-
application procedure could be adopted in the field of oral
surgery, especially when hAM/ACM is used as a covering
material. If the ocular surface is heavily inflamed, the membrane
disintegrates faster and may have to be reapplied several times
(Letko et al., 2001; Kheirkhah et al., 2008). A few authors have
reported the re-application of hAM in <15% (Chen et al., 2000;
Letko et al., 2001) to 30% of patients, 9–52 weeks after the first one
(Resch et al., 2006). During surgery, the hAM parts that remain
from the previous membrane transplantation are completely
removed (Resch et al., 2006). However, the low reapplication
rate could also be due to the fact that fixation with sutures
means additional surgical trauma for the patient. In the future,
this can be avoided with the sutureless application forms such
as AmnioClip-plus.
In the wound healing context, the amnion is replaced when
necessary in patients with third degree burns (Gajiwala and
Gajiwala, 2004). For the management of resistant vascular ulcers,
hAM was re-applied once a week for an average treatment
duration of 27 weeks (Pesteil et al., 2007); for venous leg ulcer:
three times each 2 weeks if necessary (Lullove, 2017). In diabetic
foot ulcers, patients received an average of two applications
(range: 1–11) at intervals of 4 week, or 5 weeks or more (Abdo,
2016; Lullove, 2017) or an average of 12 applications (range:
4–40) every 1–2 weeks (Valiente et al., 2018).
Resorption
When implanted, the hAM/ACM’s fate in the oral cavity is
difficult to analyze because it is not directly visible, and its
resorption has not been assessed. A pre-clinical animal study
found complete histological resorption of cryopreserved hAM
after 4 weeks (Amemiya et al., 2008). De-epithelialized and
dehydrated ACM BioXcludeTM resorbs in 8–12 weeks, according
to the manufacturer, but we were unable to find any proof-
of-concept publications. Moreover, Kumar suggests that hAM
has excellent acceptability with bone grafts by demonstrating
good containment of the material and that it resorbs without
the formation of voids and detritus (Kumar et al., 2015).
Nevertheless, hAM/ACM effects can be evaluated by direct
observation of epithelialization or keratinization in the graft area.
Epithelialization begins faster with cryopreserved hAM (from 3
to 6 days, with a mature epithelium at 2 weeks) compared to de-
epithelialized and dehydrated ACM (from 2 weeks, with a mature
epithelium at 4 weeks). Improvement of keratinized gingiva was
only reported for lyophilized hAM and ACM formats (Arai et al.,
2012; Tsuno et al., 2014; Jain et al., 2017; De Angelis et al., 2019).
When used as a cover, lyophilized or dried amnion were
nearly invisible after 7–10 days; complete resorption was achieved
after 2 weeks. When using fresh or glycerol-preserved hAM, full
resorption occurred slower, i.e., after 3 weeks. Animals studies
showed complete resorption after 2 weeks with a cryopreserved
hAM and 5 weeks with a multilayered one (Amemiya et al.,
2010; Kesting et al., 2010). Complete epithelialization occurred
faster with a lyophilized hAM (3 weeks) than the cryopreserved
(4 weeks) or dried form (6 weeks). A good balance between
resorption and epithelization is the objective.
Membrane fate is naturally easier to assess in ophthalmology
or wound healing area. The formation of an epithelial layer
is critical, since failure of proper epithelialization precludes
hAM integration in ocular healing (Nubile et al., 2011). It also
points to the role of epithelial/stromal interactions in facilitating
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hAM epithelialization by corneal epithelial cells and corneal
stroma-derived cell migration into the transplanted amnion
(Resch et al., 2006).
When used as a graft, hAM becomes incorporated into the
substratum of the host epithelium (cornea and conjunctiva) and
persists for a long time (Dua et al., 2004). Lee reported that
resorption occurred between 2 and 14 months follow-up in some
patients; for other patients, an afterglow of intact hAM was
found after 19 months follow-up (Lee and Tseng, 1997). On the
contrary, Letko et al. (2001) reported that the membrane dissolves
under the bandage contact lens in 4 weeks after surgery. After
applying multilayer hAM, Kruse reported gradual dissolution
over a period of 12 months, but stromal thickness remained
stable (Kruse et al., 1999), while Hanada reported 15 months
(Hanada et al., 2001). Using the overlay, inlay or sandwich
surgical techniques, Resch et al. (2006) reported that integrated
hAM was found in 18 of 24 corneas up to approximatively
20 months after transplantation.
Used as a patch, the membrane usually falls off, often earlier
than desired, or may eventually be removed (Dua et al., 2004).
Chen reported that in some cases, hAM dissolved between
10 days and 1 month (Chen et al., 2000); others found 1–2 months
after transplantation (Resch et al., 2006).
Mermet et al. (2007) reported that hAM had adhered to the
wound bed 1 week after transplantation and the take rate of
hAM was 100%. They hypothesized that hAM does not survive in
chronic wounds after 2–4 weeks. In one of the review co-author’s
experiments, hAM was observed 24 h after its wound application
and no signs of its presence were found (unpublished results).
Common Beneficial Role of hAM/ACM in
Oral Mucosa and Skin Wound Healing
The healing of oral mucosal wounds goes through similar stages
as that of skin wounds; however it is faster with minimal
to no scar formation coupled with a smaller inflammatory
response with less neutrophil, macrophage, and T-cell infiltration
(Turabelidze et al., 2014). Keratinocyte function is critical for
effective wound re-epithelialization, an essential part of the
remodeling phase of wound healing. Based on gene expression
profiles, proliferation and migration rate of keratinocytes from
mucosa is much more rapid than skin keratinocytes (Turabelidze
et al., 2014). In wound healing, there is strong evidence about
the intimate role of amnion in the stimulation of keratinocyte
proliferation and migration because of its effect on the TGFβ
signaling pathways (Liarte et al., 2020). These data allow us to
envision a very favorable effect of the hAM and this, in a less
deleterious environment.
GRAFT STORAGE AND EFFECT ON ITS
PROPERTIES
There is an on-going debate in the literature about hAM
properties that are relevant for oral applications, i.e., mechanical
strength, degradation or adhesion properties. This could be
explained by how the processing applied to hAM affects its
properties. A decellularization treatment is often applied to
hAM. It removes the major immunogenic cellular components,
membrane-associated antigens, and soluble proteins, thus
preventing initiation of a cell-mediated or humoral immune
response and subsequent degradation and rejection once
implanted into a patient, guaranteeing its antigenicity (Courtman
et al., 1994; Wilshaw et al., 2006). It is responsible for a
significant decrease in hAM thickness without significantly
decreasing its ultimate tensile strength, extensibility, or elasticity
(Wilshaw et al., 2006).
Lyophilization or dehydration are often applied to hAM, and
they are frequently combined with decellularization and gamma
irradiation. One major advantage of lyophilized or (hyper)dried
products is that they can be cut easily to the desired size and shape
with scissors just before application (Arai et al., 2012; Koob et al.,
2016). The second advantage is that the hAM can be preserved
for a long time at room temperature without deterioration,
simplifying the transport and storage condition and, therefore,
decreasing the cost of the product (Ilic et al., 2016; Koob et al.,
2016). In addition, the graft is usable as it is, contrary to glycerol-
preserved membranes that require thawing and rinsing for
approximatively 1 h. Moreover, it returns to a layered structure
like that of fresh amnion when it absorbs water, thickens and
becomes flaccid, and its transparency increases, suggesting that
the membrane may have sufficient strength (Arai et al., 2012).
Once hydrated, the tissue matrix is bioactive, can be decorated by
matrix metalloproteinases and remodeled by host cells, becoming
incorporated into host tissue and eventually replaced with native
host tissue (Koob et al., 2016). Lyophilization appears to decrease
the thickness and strength of the membrane; however, it improves
its adhesion properties compared to fresh and cryopreserved
hAM (Niknejad et al., 2011). Gurinsky (2009) reported the ability
of processed dehydrated amnion to self-adhere, reducing surgical
time and eliminating the need for sutures in the management
of gingival recession. Originally designed for ophthalmological
use, their current indications have also been extended to wound
healing, including diabetic foot, venous leg ulcers and lower third
nasal reconstruction (Fetterolf and Snyder, 2012; Koob et al.,
2016; Laurent I. et al., 2017; Lullove, 2017; Xue et al., 2018) as
well as oral and maxillo-facial surgery as shown in this review.
These modifications of hAM properties are confirmed by
recent studies comparing fresh hAM (F-hAM), cryopreserved
hAM (C-hAM), lyophilized hAM (L-hAM) and decellularized
then lyophilized hAM (D-hAM) (Fenelon et al., 2019; Fenelon
et al., 2020). We reported in in vivo studies that F-hAM and
D-hAM were significantly stronger than C-hAM and L-hAM. We
observed that the decellularization process increased the physical
and mechanical properties of D-hAM. It made hAM significantly
more stretchable than F-hAM, significantly enhancing the
tearing strength and significantly decreasing the hAM’s rate of
resorption. It also improved in vitro and in vivo osteogenic
potential. It was interesting to note that the cryopreservation
process did not affect some of its biomechanical properties
(Fenelon et al., 2020). Similarly, repeated freezing procedures
impacted cell viability but not histological and ultrastructure
analysis (Pogozhykh et al., 2020).
In our literature review, we found that cryopreserved hAM
had been tested in six studies, with lyophilized (preferably)
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and dried formats being tested in 12 clinical studies in total.
Cryopreserved hAM was often tested as a covering. In contrast,
lyophilized and dried formats were only implanted. Surprisingly,
because of the time required to confirm the mother’s status
after birth and because of the storage facility, fresh and
glycerol-preserved hAM were used as covering graft material
in four studies.
The decellularization process, coupled to lyophilization or
dehydration, often with additional gamma sterilization, make
chorion and ACM a novel and safe option for oral and
periodontal surgery.
ACM is only used as an implanted dehydrated membrane
in six studies, sometimes de-epithelized and irradiated. Some
authors reported that denuded (de-epithelized) hAM promotes
better cell proliferation and differentiation, better structural
integrity, as well as more uniform cell outgrowth compared
to intact hAM (epithelialized) (Koizumi et al., 2000; Koizumi
et al., 2007). Hence, it has been the preferred choice for ocular
surface reconstruction. In our analysis, de-epithelization of the
dehydrated ACM did not contribute to faster epithelization.
In addition to being easy to be manipulate because of
its thickness (around 300 µm), ACM also has more growth
factors compared to hAM (Koob et al., 2015; McQuilling
et al., 2017). Moreover, the decellularization process ensures
the safety of chorion and ACM potentially contaminated by
maternal cells (Heazlewood et al., 2014; Sardesai et al., 2017).
However, although their clinical use has been proven, to
our knowledge, their use in Europe is not yet widespread.
In this overview, we have chosen not to address the use
of chorion since ACM obviously shares some of the same
properties (lyophilized or dehydrated format, handling, rate of
resorption) and its effectiveness has been described recently
(Gulameabasse et al., 2020).
CONCLUSION
While the literature has largely described hAM grafting in
ophthalmology and wound healing, its application in oral
surgery remains a technical challenge. The required surgical
procedure has not been sufficiently described or defined
in the literature, especially regarding the application side,
folding or suturing. When hAM is used as a dressing,
there is no consensus about the need for an additional
protective coverage, contrary to ophthalmology or wound
healing indications. For the eyes, two clear applications
exist: “graft or inlay technique” and “patch or onlay/overlay
technique.”
We propose a specific nomenclature for hAM/ACM
application in the oral cavity beyond the terms “implanted
membrane” or “covering graft material” used in this overview:
– “implantation”: the membrane is buried and completely
covered by the gum
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– “apposition”: the membrane is applied against the site to
be treated, not sutured, left exposed in the mouth and
stabilized by any means (cross stitches, pressure dressing,
palatal plates, etc.)
– “whole covering graft material”: the membrane is applied
against the site to be treated, sutured to adjacent mucosa
or underlying mucosa, fully left exposed in the mouth and
protected by any means (cross stitches, pressure dressing,
palatal plates, etc.).
In case of bone exposure, an additional surgery could be
defined as “partial covering graft material” where the membrane
is applied against the bone, buried under the wound edges,
sutured to adjacent mucosa or underlying mucosa, left partially
exposed in the mouth and protected by any means (cross stitches,
pressure dressing, palatal plates, etc.).
Our overview also highlights that graft storage format does not
seem to have any impact on the surgical procedure. Although
lyophilized or dehydrated hAM/ACM may facilitate handling
and storage without the need for thawing/rinsing, to date, in
oral applications, better efficacy in terms of resorption rate,
faster re-epithelization or tissue regeneration is not supported
by clinical studies. The application size of hAM/ACM is not
always rationalized. Neither is the use of a multi-layered graft
or re-application, which are a common practice compared to
ophthalmology and wound healing, respectively. Together with
graft resorption/fate, all this information is essential in terms of
the product’s pharmacological.
Pre- and post-surgical care were mainly dependent on the
surgery itself rather than the allograft application. The few
evaluations tools reported mainly focused on the epithelialization
and/or keratinization process, sometimes illustrated by
photography, an adequate visual assessment. Imaging was not
used enough to exclusively evaluate the membrane’s effectiveness
in bone healing; the role of fetal membranes in inducing bone
formation cannot be discounted. Histology is poorly described
and requires too many invasive acts during the follow-up period.
Given this, we propose some recommendations in Table 3. We
believe that in the present overview, the collection of information
will assist oral surgeons in hAM/ACM application. Furthermore,
as a position paper, we strongly recommend fulfilling the different
criteria that we have identified to be as complete as possible in the
clinical application of hAM/ACM.
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